谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Cost-effectiveness analysis of extended thromboprophylaxis with rivaroxaban versus no prophylaxis in high-risk patients after hospitalisation for COVID-19: an economic modelling study

Caroline Cândida Carvalho de Oliveira,Leandro Barile Agati,Camilla Moreira Ribeiro,Valéria Cristina Resende Aguiar,Roberto Augusto Caffaro,Marisa da Silva Santos,Ricardo Ribeiro Alves Fernandes,Carlos Alberto da Silva Magliano,Alfonso Tafur,Alex C. Spyropoulos,Renato Delascio Lopes,Jawed Fareed,Eduardo Ramacciotti

The Lancet Regional Health - Americas（2023）

引用 0|浏览7
暂无评分
摘要
Modest funding was provided by Science Valley Research Institute, São Paulo, Brazil.
更多
查看译文
关键词
extended thromboprophylaxis,hospitalisation,rivaroxaban,cost-effectiveness,high-risk
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要